Archive for coronavirus
Answers to your questions about the COVID-19 vaccine
Update: On May 10, 2021, the U.S. Food and Drug Administration (FDA) granted emergency authorization for use of the Pfizer vaccine to prevent COVID-19 in teens between the ages of 12 and 15. This broadens the group of people eligible for the Pfizer vaccine to those ages 12 and older. To help answer the most ... Read More about Answers to your questions about the COVID-19 vaccine
Tagged: coronavirus, vaccines
The new COVID-19 virus variant: What you need to know
You’ve probably seen news reports about B.1.1.7, a newly discovered version of the SARS-CoV-2 virus that causes COVID-19. Now found in several countries, including the U.S., B.1.1.7 is quickly spreading around the world. Although B.1.1.7 seems to be more contagious, it doesn’t appear to lead to more serious illness. What else do we know about ... Read More about The new COVID-19 virus variant: What you need to know
Tagged: coronavirus, disease surveillance, research
COVID-19 vaccines: Do you know myth from fact?
Two COVID-19 vaccines — from Pfizer/BioNTtech and Moderna — have received emergency use authorization in the United States by the U.S. Food and Drug Administration (FDA). Many more are in various stages of development around the world. Several of these are in the final stage of clinical trials and could be submitted for formal authorization ... Read More about COVID-19 vaccines: Do you know myth from fact?
Tagged: coronavirus, research, vaccines
What’s the difference between the COVID-19 vaccines?
After a long, difficult year, the world had reason to celebrate in late 2020 when the U.S. Food and Drug Administration (FDA) authorized two COVID-19 vaccines for emergency use. Many more COVID-19 vaccines are in various stages of development. Several of these are in the final stage of clinical trials and could be submitted for ... Read More about What’s the difference between the COVID-19 vaccines?
Tagged: clinical trials, coronavirus, infectious diseases, vaccines
2020, the year COVID-19 tuned us into science: Part 3
Since the arrival of a new, unknown, dangerous virus in January, we entered the realm of COVID-19 science. Part 1 and Part 2 of this series recapped what we learned about how the virus spreads, how to test for it and treat it, and how COVID-19 plays out in children. This month, vaccines began to be ... Read More about 2020, the year COVID-19 tuned us into science: Part 3
Tagged: coronavirus, immunology, research, vaccines
2020, the year COVID-19 tuned us into science: Part 2
Thanks — or no thanks — to COVID-19, 2020 has been a year in which science became a household topic of discussion. Our last post recounted what we collectively learned in the spring: what COVID-19 is, who is at risk, how to test for it. As the year unfolded, there were new lessons to be learned. ... Read More about 2020, the year COVID-19 tuned us into science: Part 2
Tagged: coronavirus, drug development, mis-c, research
2020, the year COVID-19 tuned us into science: Part 1
On January 9, the World Health Organization announced a mysterious pneumonia in Wuhan, China. Few people knew it was the threat infectious disease experts had feared for decades: a fast-spreading, potentially deadly new virus with no known cure. As the first images of critically ill patients came out of China and Italy, we watched as ... Read More about 2020, the year COVID-19 tuned us into science: Part 1
Tagged: coronavirus, diagnostics, epidemiology, infectious diseases, research
How does the placenta protect unborn babies from COVID-19?
Evidence has shown that pregnancy is a risk factor for severe illness in women with COVID-19. A recent CDC study reviewed case reports of approximately 400,000 women aged 15 to 44 with symptomatic COVID-19. Those who were pregnant had a roughly tripled likelihood of ICU admission and invasive ventilation and 70 percent higher mortality. Yet ... Read More about How does the placenta protect unborn babies from COVID-19?
Hunker down and reduce your ‘transmission footprint’
In the midst of one of the worst COVID-19 surges so far, we finally have some good news. Two coronavirus vaccines, made by pharmaceutical companies Pfizer and Moderna, appear to be highly effective and safe. While data are still preliminary, it seems that the Pfizer vaccine may also have excellent efficacy in older adults. While ... Read More about Hunker down and reduce your ‘transmission footprint’
Tagged: coronavirus, infectious diseases
The new COVID-19 vaccines: Will they be safe?
Just within the past week, pharmaceutical companies have announced encouraging news about two COVID-19 vaccines in the final development phase. As more vaccine developers announce similar reports in the coming weeks and months, it’s key to remember that vaccine safety is as important as effectiveness against the virus. Fortunately, scientists have learned lessons from the ... Read More about The new COVID-19 vaccines: Will they be safe?
Tagged: clinical trials, coronavirus, infectious diseases, vaccines